Interleukin-1 as a Predictor Cytokine SARS-CoV: Article Review

Lisa Savitri, Elfred Rinaldo Kasimo, Rochmad Krissanjaya, Syntia Tanu Juwita, Ester Lianawati Antoro, Ida Septika Wulansari

Abstract


Severe acute respiratory syndrome coronavirus (SARS-CoV) is an etiologic agent of respiratory disease that has a mortality rate of 10%. IL-1 actively participates in the inflammatory response to infection. SARS-CoV-2 appears to act on the activation and maturation of IL-1?, which in turn activates other proinflammatory cytokines, such as IL-6 and TNF-. Therefore, IL-1? is part of the cytokine storm generated by coronavirus infection. Elevated levels of the IL-1 receptor antagonist (IL-1Ra) in severe cases of COVID-19, and this marker have been associated with increased viral load, loss of lung function, lung damage, and risk of death. In addition, there is an increase in IL-1? levels in patients with severe COVID-19, and this is strongly associated with lung injury. IL-1 levels are associated with the virulence of the process, and significantly higher serum levels have been observed in severe symptomatic SARS-CoV-2 cases than in mild cases or in those infected with the 2003 SARS-CoV coronavirus or 2012 MERS coronavirus.

Keywords


cytokines; interleukin-1; severe acute respiratory syndrome coronavirus (SARS-CoV)

Full Text:

PDF

References


Chen C., Zhang X.R., Ju Z.Y., He W.F. (2020) Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019and the corresponding immunotherapies. Zhonghua Shao Shang Za Zhi. 2020;36:E005. doi: 10.3760/cma.j.cn501120-20200224-00088.

Chu H., Zhou J., Wong B.H.-Y., Li C., Chan J.F.-W., Cheng Z.-S., Yang D., Wang D., Lee A.C.-Y., Li C., Yeung M.-L., Cai J.-P., Chan I.H.-Y., Ho W.-K., To K.K.-W., Zheng B.-J., Yao Y., Qin C., Yuen K.-Y. (2016) Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J. Infect. Dis. 2016;213:904–914. doi: 10.1093/infdis/jiv380.

Conti P., Ronconi G., Caraffa A., Gallenga C., Ross R., Frydas I., Kritas S. (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents. 2020;34 doi: 10.23812/CONTI-E.

C.Y., Poon L.L.M., Ng I.H.Y., Luk W., Sia S.-F., Wu M.H.S., Chan K.-H., Yuen K.-Y., Gordon S., Guan Y., Peiris J.S.M. (2005) Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J. Virol. 2005;79:7819–7826. doi: 10.1128/JVI.79.12.7819-7826.2005.

DeDiego M.L., Nieto-Torres J.L., Regla-Nava J.A., Jimenez-Guardeño J.M., Fernandez-Delgado R., Fett C., Castaño-Rodriguez C., Perlman S., Enjuanes L. (2014) Inhibition of NF-?B-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J. Virol. 2014;88:913–924. doi: 10.1128/JVI.02576-13.

Etti, Azulay E; Assy, Nimer; and Idan, Cohen (2018) Interleukin-1. In: eLS. John Wiley & Sons, Ltd: Chichester.DOI: 10.1002/9780470015902.a0028193

Hui D.S.C., Zumla A. (2019) Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect. Dis. Clin. North Am. 2019;33:869–889. doi: 10.1016/j.idc.2019.07.001.

Kritas S.K., Ronconi G., Caraffa A., Gallenga C.E., Ross R., Conti P. (2020) Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J. Biol. Regul. Homeost. Agents. 2020;34 doi: 10.23812/20-Editorial-Kritas.

Law H.K.W., Cheung C.Y., Ng H.Y., Sia S.F., Chan Y.O., Luk W., Nicholls J.M., Peiris J.S.M., Lau Y.L. (2005) Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells. Blood. 2005;106:2366–2374. doi: 10.1182/blood-2004-10-4166.

Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. (2020) HLH Across Speciality Collaboration, UK, COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0.

Liu Y., Zhang C., Huang F., Yang Y., Wang F., Yuan J., Zhang Z., Qin Y., Li X., Zhao D., Li S., Tan S., Wang Z., Li J., Shen C., Li J., Peng L.,Wu W., Cao M., Xing L., Xu Z., Chen L., Zhou C., Liu W.J., Liu L., Jiang C. (2020) 2019-novel Coronavirus (2019-nCoV) Infections Trigger an Exaggerated Cytokine Response Aggravating Lung Injury.

Nieto-Torres J.L., DeDiego M.L., Verdiá-Báguena C., Jimenez-Guardeño J.M., Regla-Nava J.A., Fernandez-Delgado R., Castaño-Rodriguez C., Alcaraz A., Torres J., Aguilella V.M., Enjuanes L. (2014) Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014;10:e1004077. doi: 10.1371/journal.ppat.1004077.

Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.-S. (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa248.

Siu K.-L., Yuen K.-S., Castaño-Rodriguez C., Ye Z.-W., Yeung M.-L., Fung S.-Y., Yuan S., Chan C.-P., Yuen K.-Y., Enjuanes L., Jin D.-Y. (2019) Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019;33:8865–8877. doi: 10.1096/fj.201802418R.

Tanaka T., Narazaki M., Kishimoto T. (2016) Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. 2016;8:959 970. doi: 10.2217/imt-2016-0020.

Turner M.D., Nedjai B., Hurst T., Pennington D.J. (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta. 2014;1843:2563–2582. doi: 10.1016/j.bbamcr.2014.05.014.

Wan S., Yi Q., Fan S., Lv J., Zhang X., Guo L., Lang C., Xiao Q., Xiao K., Yi Z., Qiang M., Xiang J., Zhang B., Chen Y. (2020) Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP) Hematology. 2020 doi: 10.1101/2020.02.10.20021832.

Yang Y., Shen C., Li J., Yuan J., Yang M., Wang F., Li G., Li Y., Xing L., Peng L., Wei J., Cao M., Zheng H., Wu W., Zou R., Li D., Xu Z., Wang H., Zhang M., Zhang Z., Liu L., Liu Y. (2020) Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. Infectious Diseases (except HIV/AIDS) 2020 doi: 10.1101/2020.03.02.20029975.

Zhang W., Zhao Y., Zhang F., Wang Q., Li T., Liu Z., Wang J., Qin Y., Zhang X., Yan X., Zeng X., Zhang S. (2020) The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin. Immunol. 2020;214 doi: 10.1016/j.clim.2020.108393.




DOI: https://doi.org/10.14421/biomedich.2023.121.187-190

Refbacks

  • There are currently no refbacks.


Bookmark and Share


Copyright (c) 2023 Lisa Savitri, Elfred Rinaldo Kasimo, Rochmad Krissanjaya, Syntia Tanu Juwita, Ester Lianawati Antoro, Ida Septika Wulansari



Biology, Medicine, & Natural Product Chemistry
ISSN 2089-6514 (paper) - ISSN 2540-9328 (online)
Published by Sunan Kalijaga State Islamic University & Society for Indonesian Biodiversity.

CC BY NC
This work is licensed under a CC BY-NC